158 related articles for article (PubMed ID: 7609154)
1. Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction.
Wang Y; Puri P; Hassan J; Miyakita H; Reen DJ
J Urol; 1995 Aug; 154(2 Pt 2):679-83. PubMed ID: 7609154
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction.
Kajbafzadeh AM; Payabvash S; Salmasi AH; Monajemzadeh M; Tavangar SM
J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927
[TBL] [Abstract][Full Text] [Related]
3. Congenital unilateral ureteropelvic junction obstruction of the rat: a useful animal model for human ureteropelvic junction obstruction?
Miller J; Hesse M; Diemer T; Haenze J; Knerr I; Rascher W; Weidner W
Urology; 2004 Jan; 63(1):190-4. PubMed ID: 14751390
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and morphometric evaluation of neuronal dysfunction in pelviureteral junction obstruction.
Gündüz M; Yurtçu M; Toy H; Abasiyanik A; Demirci S
J Pediatr Urol; 2013 Jun; 9(3):359-63. PubMed ID: 22682546
[TBL] [Abstract][Full Text] [Related]
5. The expression of epidermal growth factor and transforming growth factor-beta1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children.
Yang Y; Zhou X; Gao H; Ji SJ; Wang C
J Pediatr Surg; 2003 Nov; 38(11):1656-60. PubMed ID: 14614718
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction.
Solari V; Piotrowska AP; Puri P
J Urol; 2003 Dec; 170(6 Pt 1):2420-2. PubMed ID: 14634443
[TBL] [Abstract][Full Text] [Related]
7. Activated Hedgehog-GLI Signaling Causes Congenital Ureteropelvic Junction Obstruction.
Sheybani-Deloui S; Chi L; Staite MV; Cain JE; Nieman BJ; Henkelman RM; Wainwright BJ; Potter SS; Bagli DJ; Lorenzo AJ; Rosenblum ND
J Am Soc Nephrol; 2018 Feb; 29(2):532-544. PubMed ID: 29109083
[TBL] [Abstract][Full Text] [Related]
8. Alteration of neuronal and endothelial nitric oxide synthase and neuropeptide Y in congenital ureteropelvic junction obstruction.
Knerr I; Dittrich K; Miller J; Kummer W; Rösch W; Weidner W; Rascher W
Urol Res; 2001 Apr; 29(2):134-40. PubMed ID: 11396731
[TBL] [Abstract][Full Text] [Related]
9. Glial cell line-derived neurotrophic factor and synaptophysin expression in pelviureteral junction obstruction.
Demirbilek S; Edali MN; Gürünlüoğlu K; Türkmen E; Taş E; Karaman A; Akin M; Aksoy RT; Celbis O; Uzün I
Urology; 2006 Feb; 67(2):400-5. PubMed ID: 16461096
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Cajal like cells and innervation in intrinsic ureteropelvic junction obstruction.
Kuvel M; Canguven O; Murtazaoglu M; Albayrak S
Arch Ital Urol Androl; 2011 Sep; 83(3):128-32. PubMed ID: 22184836
[TBL] [Abstract][Full Text] [Related]
11. Endopyelotomy failure is associated with reduced transforming growth factor-beta.
Jabbour ME; Goldfischer ER; Anderson AE; Smith AD; Kushner L
J Urol; 1998 Dec; 160(6 Pt 1):1991-4. PubMed ID: 9817307
[TBL] [Abstract][Full Text] [Related]
12. The vesico-ureteric junction in three cases of primary obstructive megaureter associated with ectopic ureteric insertion.
Dixon JS; Jen PY; Yeung CK; Gosling JA
Br J Urol; 1998 Apr; 81(4):580-4. PubMed ID: 9598631
[TBL] [Abstract][Full Text] [Related]
13. Trifid pelvis and controlateral bifid ureter with bilateral ureteropelvic junction obstruction.
Sapin E; Kurzenne JY; Bargy F; Mayer M; Bienaymé J
Eur Urol; 1988; 15(1-2):144-5. PubMed ID: 3215229
[TBL] [Abstract][Full Text] [Related]
14. The expression of platelet-derived growth factor receptor alpha-positive cells in the stenotic tissue of ureteropelvic junction obstruction in children
.
Wang T; Zhang W; Han W
Clin Nephrol; 2020 Apr; 93(4):195-202. PubMed ID: 32049626
[TBL] [Abstract][Full Text] [Related]
15. Complete duplication of the ureter with ureteropelvic junction obstruction of the lower pole of the kidney: imaging findings.
Fernbach SK; Zawin JK; Lebowitz RL
AJR Am J Roentgenol; 1995 Mar; 164(3):701-4. PubMed ID: 7863898
[TBL] [Abstract][Full Text] [Related]
16. The operative management of recurrent ureteropelvic junction obstruction.
Rohrmann D; Snyder HM; Duckett JW; Canning DA; Zderic SA
J Urol; 1997 Sep; 158(3 Pt 2):1257-9. PubMed ID: 9258188
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix degradation and reduced neural density in children with intrinsic ureteropelvic junction obstruction.
Kaya C; Bogaert G; de Ridder D; Schwentner C; Fritsch H; Oswald J; Radmayr C
Urology; 2010 Jul; 76(1):185-9. PubMed ID: 20303154
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of ureteropelvic junction obstruction: experimental and clinical observations.
Koff SA; Hayden LJ; Cirulli C; Shore R
J Urol; 1986 Jul; 136(1 Pt 2):336-8. PubMed ID: 3723684
[TBL] [Abstract][Full Text] [Related]
19. The kidney in congenital ureteropelvic junction obstruction: a spectrum from normal to nephrectomy.
Rosen S; Peters CA; Chevalier RL; Huang WY
J Urol; 2008 Apr; 179(4):1257-63. PubMed ID: 18280506
[TBL] [Abstract][Full Text] [Related]
20. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.
Mesrobian HG; Mitchell ME; See WA; Halligan BD; Carlson BE; Greene AS; Wakim BT
J Urol; 2010 Aug; 184(2):709-14. PubMed ID: 20639044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
